Results 101 to 110 of about 105,814 (267)
Food Chemistry International, EarlyView.Combination of the Leptadenia hastata leaf and the Syzygium aromaticum bud demonstrated hypolipidemic and antioxidant activities in a hyperlipidemic rat model. Combination of the two plants inhibited HMG‐CoA reductase activity, and the docking analysis revealed interacted well and formed binding complexes within the binding pocket of the enzyme ...
Farida Salisu Dabo +7 more
wiley +1 more source
Кардиоваскулярная терапия и профилактика, 2009 Aim. To study pharmacodynamics and clinical effectiveness of clopidogrel and atorvastatin in patients with acute coronary syndrome (ACS) and hyperlipidaemia (HLP).Material and methods.
A. S. Sivkov +6 more
doaj
SAFETY EVALUATION OF STATIN IN YOGYAKARTA, INDONESIA [PDF]
, 2009 Background : The 3-hydroxy-3-methylglutaryl-coenzyme (HMG-Co-A) reductase inhibitors, also known as statins, are the most effective class of drugs for lowering serum Low-Density Lipoprotein cholesterol (LDL-c)concentrations.
Anni, Anni +3 more
core
Expired atorvastatin drug as corrosion inhibitor for mild steel in hydrochloric acid solution
International Journal of Industrial Chemistry, 2017 The application of expired drugs as corrosion inhibitors provides a cost effective and environmentally benign alternative to otherwise tedious and costly disposal/degradation process. In this context, we herein investigate the use of expired atorvastatin
Priyanka Singh +4 more
semanticscholar +1 more source
Caspian Journal of Internal Medicine, 2022 Background: Oral mucositis is a troublesome symptom for people who receive radiotherapy and chemotherapy and it is a dose-dependent factor. Atorvastatin is a HMG-CoA reductase inhibitors and various studies have proven its anti-inflammatory effects.
Shahram Ala +4 more
doaj
EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES
Рациональная фармакотерапия в кардиологии, 2016 Large epidemiological trails shown that hypercholesterolemia is one of the main risk factor of ischemic heart disease (IHD). Correction of the hypercholesterolemia with GmGKoA reductase inhibitors (statins) essentially reduces IHD morbidity and mortality.
A. N. Meshkov
doaj +1 more source
Effect of atorvastatin on the gut microbiota of high fat diet-induced hypercholesterolemic rats
Scientific Reports, 2018 The aim of the present study was to investigate alterations in gut microbiota associated with hypercholesterolemia and treatment with atorvastatin, a commonly prescribed cholesterol-lowering drug.
T. Khan +7 more
semanticscholar +1 more source
The carbon footprint of different medication packaging items at an Australian tertiary hospital
Journal of Pharmacy Practice and Research, EarlyView.Abstract Background Medication packaging contributes significantly to the overall carbon footprint of pharmaceuticals. Packaging design and material choices greatly influence environmental impact. Aim To assess the carbon footprint of packaging for a range of medications on an Australian tertiary hospital formulary and identify opportunities to reduce ...
Michael J. Loftus +9 more
wiley +1 more source
Atorvastatin Induced Erythrocytes Membrane Blebbing
Dose-Response, 2019 Atorvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzymeA reductase, is usually used for the treatment of hypercholesterolemia. Besides its pharmacological and side actions, its toxic effects on human nucleus devoid of erythrocytes are still ...
Rumaisa Bashir Rana +7 more
doaj +1 more source
Atorvastatin and flaxseed dietary treatments improve dyslipidemia and liver injuries in a diet-induced rat model of non-alcoholic fatty liver disease [PDF]
Avicenna Journal of PhytomedicineObjective: Non-alcoholic fatty liver disease (NAFLD) as the most common chronic liver disease is associated with metabolic disorders including dysregulated lipid and glucose metabolism.
Zahra Eslami +4 more
doaj +1 more source